ZYVORZIA Trademark

Trademark Overview


On Friday, January 8, 2021, a trademark application was filed for ZYVORZIA with the United States Patent and Trademark Office. The USPTO has given the ZYVORZIA trademark a serial number of 79306237. The federal status of this trademark filing is REGISTERED as of Tuesday, November 9, 2021. This trademark is owned by Glaxo Group Limited. The ZYVORZIA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines
zyvorzia

General Information


Serial Number79306237
Word MarkZYVORZIA
Filing DateFriday, January 8, 2021
Status700 - REGISTERED
Status DateTuesday, November 9, 2021
Registration Number6549776
Registration DateTuesday, November 9, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 24, 2021

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, March 17, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Sunday, July 30, 2023CHANGE OF NAME/ADDRESS REC'D FROM IB
Saturday, March 12, 2022NOTIFICATION PROCESSED BY IB
Wednesday, February 23, 2022FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, February 22, 2022FINAL DISPOSITION PROCESSED
Thursday, December 9, 2021GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, November 9, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, August 24, 2021PUBLISHED FOR OPPOSITION
Sunday, August 22, 2021NOTIFICATION PROCESSED BY IB
Wednesday, August 4, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, August 4, 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, August 4, 2021NOTICE OF PUBLICATION
Tuesday, July 20, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 19, 2021ASSIGNED TO EXAMINER
Tuesday, March 23, 2021APPLICATION FILING RECEIPT MAILED
Wednesday, March 17, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 16, 2021LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, March 11, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB